📖
Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.
Riolo G, Dosi C, Parravicini S, Zanin R, Cheli M, Grigoli EG, Canciello A, Andreetta F, Masson R, Bonanno S, Marcuzzo S, Maggi L

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Ann Clin Transl Neurol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.
Author / Organization Riolo G, Dosi C, Parravicini S, Zanin R, Cheli M, Grigoli EG, Canciello A, Andreetta F, Masson R, Bonanno S, Marcuzzo S, Maggi L
Subject & Discipline Ann Clin Transl Neurol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-135794
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »